No Data
No Data
New Analyst Forecast: $MRVI Given $5.0 Price Target
Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $5
Analysts Offer Insights on Healthcare Companies: Opthea Limited (OtherCKDXF), Outset Medical (OM) and Maravai Lifesciences Holdings (MRVI)
Is Maravai LifeSciences Holdings, Inc. (MRVI) the Top Stock to Buy According to 12 West Capital Management?
Maravai LifeSciences Is Maintained at Equal-Weight by Morgan Stanley
Trump Media & Technology Group, BitFuFu, Mobileye Global And Other Big Stocks Moving Higher On Tuesday